NCT04748926View on ClinicalTrials.gov

Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 7, 2021

Primary Completion Date

May 21, 2021

Study Completion Date

May 21, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

rilzabrutinib SAR444671

Pharmaceutical form: caplet Route of administration: oral

DRUG

rilzabrutinib SAR444671

Pharmaceutical form: Oral Formulation 1 tablets Route of administration: oral

DRUG

rilzabrutinib SAR444671

Pharmaceutical form: Oral Formulation 2 tablets Route of administration: oral

Trial Locations (1)

5000

Investigational Site, Adelaide

All Listed Sponsors
lead

Principia Biopharma, a Sanofi Company

INDUSTRY

NCT04748926 - Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants | Biotech Hunter | Biotech Hunter